Belite Bio (BLTE) Other Non-Current Assets (2021 - 2026)

Belite Bio's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $289.4 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 5789.44% year-over-year to $289.4 million; the TTM figure through Mar 2026 stood at $289.4 million (up 5789.44% YoY), while the FY2025 annual figure was $286.3 million, up 277845.63% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $289.4 million, up from $286.3 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $289.4 million in Q1 2026, with the low at $88000.0 in Q4 2022.
• The 5-year median for Other Non-Current Assets is $3.1 million (2023), against an average of $43.2 million.
• Peak annual rise in Other Non-Current Assets reached 277845.63% in 2025, while the deepest fall reached 97.78% in 2025.
• Belite Bio's Other Non-Current Assets stood at $88000.0 in 2022, then grew by 18.18% to $104000.0 in 2023, then fell by 0.96% to $103000.0 in 2024, then soared by 277845.63% to $286.3 million in 2025, then gained by 1.09% to $289.4 million in 2026.
• Business Quant data shows BLTE's Other Non-Current Assets at $289.4 million in Q1 2026, $286.3 million in Q4 2025, and $101000.0 in Q3 2025.